Orion reported EUR98.9M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Hikma Pharmaceutical USD 288M 149M Dec/2025
Oriola-kd EUR 13M 3.1M Sep/2025
Recordati EUR 201.58M 8.82M Jun/2026
UCB EUR 1.47B 193M Dec/2025